Granted its one thing to approve a drug vs. accept/review but considering FDA reconsidered and accepted basically an open label trial in leu of a RCT trial seems to go against their standard so wouldn't that alone imply some sort of pressure?
I also think Janet Woodcock didn't do the agency any favors by being so chummy with the families.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.